Search

Your search keyword '"Kim, S. J."' showing total 5,479 results
Start Over Author "Kim, S. J."
5,479 results on '"Kim, S. J."'

109. H-dibaryon search by KEK-E522 : Search for the ΛΛ resonance in 12C (K−, K+ΛΛX) using a scintillating fiber active target

Author

Yoon, C. J., Akikawa, H., Aoki, K., Fukao, Y., Funahashi, H., Hayata, M., Imai, K., Miwa, K., Okada, H., Saito, N., Sato, H. D., Shoji, K., Takahashi, H., Taketani, K., Asai, J., Kurosawa, M., Ieiri, M., Hayakawa, T., Kishimoto, T., Sato, A., Shimizu, Y., Yamamoto, K., Yoshida, T., Hibi, T., Nakazawa, K., Ahn, J. K., Choi, B. H., Kim, S. J., Kim, S. H., Park, B. D., Park, I. G., Song, J. S., Yoon, C. S., Tanida, K., Ohnishi, A., Pochodzalla, Josef, editor, and Walcher, Thomas, editor

Published
2007
Full Text
View/download PDF

110. First observation of the ΣN decay of the S = −2 system

Author

Watanabe, T., Ahn, J. K., Akikawa, H., Aoki, S., Arai, K., Bahk, S. Y., Baik, K. M., Bassalleck, B., Chung, J. H., Chung, M. S., Davis, D. H., Fukuda, T., Hayata, H., Hoshino, K., Ichikawa, A., Ieiri, M., Imai, K., Iwata, Y. H., Iwata, Y. S., Kakita, Y., Kanda, H., Kaneko, M., Kawai, T., Kawasaki, M., Kim, C. O., Kim, J. Y., Kim, S. J., Kim, S. H., Kondo, Y., Kouketsu, T., Lee, Y. L., McNabb, J. W. C., Mitsuhara, M., Nagase, Y., Nagoshi, C., Nakazawa, K., Noumi, H., Ogawa, S., Okabe, H., Oyama, K., Park, H. M., Park, I. G., Parker, J., Ra, Y. S., Rhee, J. T., Rusek, A., Shibuya, H., Sim, K. S., Saha, P. K., Seki, D., Sekimoto, M., Song, J. S., Takahashi, H., Takahashi, T., Takeutchi, F., Tanaka, H., Tanida, K., Tojo, J., Torii, H., Torikai, S., Tsunemi, T., Tovee, D. N., Ushida, N., Yamamoto, K., Yasuda, N., Yang, J. T., Yoon, C. J., Yoon, C. S., Yosoi, M., Yoshida, T., Zhu, L., Pochodzalla, Josef, editor, and Walcher, Thomas, editor

Published
2007
Full Text
View/download PDF

125. S209: PRIMARY RESULTS FROM THE PHASE 3 SHINE STUDY OF IBRUTINIB IN COMBINATION WITH BENDAMUSTINE-RITUXIMAB (BR) AND R MAINTENANCE AS A FIRST-LINE TREATMENT FOR OLDER PATIENTS WITH MANTLE-CELL LYMPHOMA

Author

Wang, M. L., primary, Jurczak, W., additional, Jerkeman, M., additional, Trotman, J., additional, Zinani, P. L., additional, Belada, D., additional, Boccomini, C., additional, Flinn, I. W., additional, Giri, P., additional, Goy, A., additional, Hamlin, P. A., additional, Hermine, O., additional, Hernández-Rivas, J.-Á., additional, Hong, X., additional, Kim, S. J., additional, Lewis, D., additional, Mishima, Y., additional, Özcan, M., additional, Perini, G. F., additional, Pocock, C., additional, Song, Y., additional, Spurgeon, S. E., additional, Storring, J. M., additional, Walewski, J., additional, Zhu, J., additional, Qin, R., additional, Henninger, T., additional, Deshpande, S., additional, Howes, A., additional, Le Gouill, S., additional, and Dreyling, M., additional

Published
2022
Full Text
View/download PDF

129. North Ecliptic Pole merging galaxy catalogue

Author

Pearson, W. J., primary, Suelves, L. E., additional, Ho, S. C.-C., additional, Oi, N., additional, Brough, S., additional, Holwerda, B. W., additional, Hopkins, A. M., additional, Huang, T.-C., additional, Hwang, H. S., additional, Kelvin, L. S., additional, Kim, S. J., additional, López-Sánchez, Á. R., additional, Małek, K., additional, Pearson, C., additional, Poliszczuk, A., additional, Pollo, A., additional, Rodriguez-Gomez, V., additional, Shim, H., additional, Toba, Y., additional, and Wang, L., additional

Published
2022
Full Text
View/download PDF

135. Antipsychotics and Risk of Neuroleptic Malignant Syndrome: A Population-Based Cohort and Case-Crossover Study

Author

Frank M.C. Besag, Kim S. J. Lao, Esther W. Chan, Ian C. K. Wong, Jiaxi Zhao, Joseph E Blais, David J. Castle, Wing Chung Chang, and Lam Lam

Subjects
education.field_of_study, medicine.medical_specialty, Pediatrics, business.industry, medicine.medical_treatment, Incidence (epidemiology), Population, Odds ratio, medicine.disease, 030227 psychiatry, Neuroleptic malignant syndrome, 03 medical and health sciences, Psychiatry and Mental health, 0302 clinical medicine, Epidemiology, Medicine, Pharmacology (medical), Neurology (clinical), business, Antipsychotic, education, 030217 neurology & neurosurgery, Cause of death, Cohort study
Abstract

Neuroleptic malignant syndrome (NMS) is a rare and acute adverse drug reaction associated with antipsychotic therapy. However, few data on the risk and epidemiology of NMS are available. The aim of this study was to ascertain the incidence risk and all-cause mortality of NMS associated with antipsychotic use, and to assess the association of recent antipsychotic exposure and NMS. We did a population-based study using data from the Hong Kong Hospital Authority’s Clinical Data Analysis and Reporting System database. Cases had a first diagnosis of NMS between 1 January 2004 and 30 November 2017. A case-crossover analysis was used to compare antipsychotic exposure 30 days before the diagnosis of NMS (index date) and a reference period 91–120 days before the index date. To adjust for potential time trends in antipsychotic exposure, we sampled from cases to match current cases and future cases, and further adjusted for select medications and acute medical conditions. 297,647 patients were prescribed antipsychotics, and the incidence risk of NMS was 0.11%. Of the 336 cases included in the case-crossover analysis, 20 (6%) died within 30 days after the index date; only one case had NMS recorded as the primary cause of death. When compared with the reference period, cases were more frequently prescribed multiple antipsychotics (15.8% vs 26.8%; standardized mean difference [SMD] 0.27) and short-acting injectable antipsychotics (3.6% vs 13.7%; SMD 0.37) during the 30 days prior to the diagnosis of NMS. Odds ratios for antipsychotic exposure in the case-crossover, case-crossover adjusted for time trend, and case-crossover adjusted for time trend and potential confounders analysis were 8.00 (95% confidence interval 3.42–18.69), 5.88 (2.46–14.04), and 4.77 (1.95–11.66). Our results suggest that recent use of antipsychotics is associated with NMS. Although a case-only design inherently controls for confounding by time-invariant factors, residual confounding by acute medical conditions with similar presentations to NMS cannot be fully excluded.

Published
2020

144. eBlock37 Microreactor Electrical Demonstration Unit.

Author

Gaspar, L. M., Giordano, D. A., Greenfield, N. A., Kim, S. J., Kubic, F. A., Middlemas, M. R., Pizarro, A. J., Saeger, W. J., Sweetland, K. M., and Reid, R. S.

Abstract

The eBlock37 is a subscale electrically heated and heat-pipe-cooled prototype of a fast spectrum microreactor that is under development at Los Alamos National Laboratory. The prototype consists of an electrically heated core and gas-cooled heat exchanger. These subassemblies, both built from 316 L stainless steel, are thermally linked by an array of 37 sodium heat pipes that transfer a nominal 100 kW from the core at 700°C. An overarching objective of this effort is to overcome challenges associated with core block and heat exchanger manufacture and integration of high-temperature heat pipes into the assembly. Components that would be safety critical in an actual reactor, such as the heat pipe wicks, are being built under a Nuclear Quality Assurance 1 quality program. The completed assembly is intended for non-nuclear electrically heated testing, which will be conducted at a demonstration facility at Idaho National Laboratory. This paper provides a top-level summary of the efforts to date. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results